The downstream targets of JAK2, the STAT proteins, have also been implied in both the pathogenesis of CTCL and the mechanism of action of cucurbitacins [27,29,30,[32], [33], [34]]. Here, JAK2 is linked to primary cutaneous T-cell non-Hodgkin lymphoma.